NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 82 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-31: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-12-31: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-12-22: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-12-16: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 11,309 owned after | $9.96 exercise price | 2016-01-04 | |
| 2015-12-31 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,200 2,974 owned after | $2.11 exercise price | 2016-01-04 | |
| 2015-12-22 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 55,397 owned after | $11.03 exercise price | 2015-12-23 | |
| 2015-12-16 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 19,309 owned after | $9.96 exercise price | 2015-12-17 | |
| 2015-12-15 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,863 54,802 owned after | $14.05 exercise price | 2015-12-17 | |
| 2015-12-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 2,479 owned after | $9.96 exercise price | 2015-12-15 | |
| 2015-12-10 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,274 30,000 owned after | $2.11 exercise price | 2015-12-11 | |
| 2015-12-08 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,413 20,109 owned after | $9.96 exercise price | 2015-12-09 | |
| 2015-11-16 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 3,099 owned after | $9.96 exercise price | 2015-11-17 | |
| 2015-11-12 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −342 6,174 owned after | $2.11 exercise price | 2015-11-16 | |
| 2015-11-12 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,213 21,522 owned after | $9.96 exercise price | 2015-11-16 | |
| 2015-11-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 58,397 owned after | $11.03 exercise price | 2015-11-12 | |
| 2015-11-10 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,863 57,665 owned after | $14.05 exercise price | 2015-11-12 | |
| 2015-11-10 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 39,274 owned after | $2.11 exercise price | 2015-11-12 | |
| 2015-11-10 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 7,000 owned after | $18.55 exercise price | 2015-11-12 | |
| 2015-11-09 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 49,274 owned after | $2.11 exercise price | 2015-11-09 | |
| 2015-11-04 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 23,735 owned after | $9.96 exercise price | 2015-11-05 | |
| 2015-11-04 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,591 60,528 owned after | $14.05 exercise price | 2015-11-04 | |
| 2015-11-03 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −826 27,735 owned after | $9.96 exercise price | 2015-11-05 | |
| 2015-11-03 | Brown Robert S. Officer (President, NxStage Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −44,400 0 owned after | $9.96 exercise price | 2015-11-04 | |
| 2015-10-16 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 59,274 owned after | $2.11 exercise price | 2015-10-16 | |
| 2015-10-15 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 69,274 owned after | $2.11 exercise price | 2015-10-15 | |
| 2015-10-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 3,719 owned after | $9.96 exercise price | 2015-10-14 | |
| 2015-10-08 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −339 6,516 owned after | $2.11 exercise price | 2015-10-09 | |
| 2015-10-08 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 28,561 owned after | $9.96 exercise price | 2015-10-09 | |
| 2015-09-17 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 79,274 owned after | $2.11 exercise price | 2015-09-17 | |
| 2015-09-16 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 89,274 owned after | $2.11 exercise price | 2015-09-16 | |
| 2015-09-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 4,339 owned after | $9.96 exercise price | 2015-09-15 | |
| 2015-09-09 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 29,561 owned after | $9.96 exercise price | 2015-09-11 | |
| 2015-09-09 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −339 6,855 owned after | $2.11 exercise price | 2015-09-11 | |
| 2015-08-17 | Brown Robert S. Officer (President, NxStage Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,825 0 owned after | $2.11 exercise price | 2015-08-18 | |
| 2015-08-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 4,959 owned after | $9.96 exercise price | 2015-08-17 | |
| 2015-08-13 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 99,274 owned after | $2.11 exercise price | 2015-08-17 | |
| 2015-08-12 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −339 7,194 owned after | $2.11 exercise price | 2015-08-14 | |
| 2015-08-12 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,413 30,561 owned after | $9.96 exercise price | 2015-08-14 | |
| 2015-08-12 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 109,274 owned after | $2.11 exercise price | 2015-08-14 | |
| 2015-08-07 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −826 31,974 owned after | $9.96 exercise price | 2015-08-10 | |
| 2015-08-04 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 32,800 owned after | $9.96 exercise price | 2015-08-06 | |
| 2015-07-14 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 5,579 owned after | $9.96 exercise price | 2015-07-15 | |
| 2015-07-09 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −339 7,533 owned after | $2.11 exercise price | 2015-07-13 | |
| 2015-06-18 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 119,274 owned after | $2.11 exercise price | 2015-06-19 | |
| 2015-06-17 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 129,274 owned after | $2.11 exercise price | 2015-06-19 | |
| 2015-06-15 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 6,199 owned after | $9.96 exercise price | 2015-06-16 | |
| 2015-06-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −339 7,872 owned after | $2.11 exercise price | 2015-06-10 | |
| 2015-06-10 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 33,800 owned after | $9.96 exercise price | 2015-06-10 | |
| 2015-05-21 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-21 | Straube Barry M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-21 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-21 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-21 | Mixer Jean K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-21 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-21 | FUNARI ROBERT G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,724 19,724 owned after | $16.81 exercise price | 2015-05-26 | |
| 2015-05-20 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $13.88 exercise price | 2015-05-22 | |
| 2015-05-18 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −620 6,819 owned after | $9.96 exercise price | 2015-05-19 | |
| 2015-05-13 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $2.11 exercise price | 2016-04-15 | |
| 2015-05-13 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 8,211 owned after | $2.11 exercise price | 2015-05-15 | |
| 2015-05-12 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 139,274 owned after | $2.11 exercise price | 2015-05-13 | |
| 2015-04-21 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 8,361 owned after | $2.11 exercise price | 2015-04-22 | |
| 2015-04-21 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 34,800 owned after | $9.96 exercise price | 2015-04-22 | |
| 2015-04-17 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 149,274 owned after | $2.11 exercise price | 2015-04-21 | |
| 2015-04-16 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 159,274 owned after | $2.11 exercise price | 2015-04-17 | |
| 2015-03-31 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 35,600 owned after | $9.96 exercise price | 2015-04-02 | |
| 2015-03-26 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 8,511 owned after | $2.11 exercise price | 2015-03-30 | |
| 2015-03-18 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 169,274 owned after | $2.11 exercise price | 2015-03-19 | |
| 2015-03-17 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 179,274 owned after | $2.11 exercise price | 2015-03-19 | |
| 2015-03-17 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −136 0 owned after | $4.54 exercise price | 2015-03-19 | |
| 2015-03-17 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $13.88 exercise price | 2015-03-19 | |
| 2015-03-13 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $13.88 exercise price | 2015-03-17 | |
| 2015-03-03 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +53,315 53,315 owned after | $16.66 exercise price | 2015-03-05 | |
| 2015-03-03 | Brown Robert S. Officer (President, NxStage Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,618 65,618 owned after | $16.66 exercise price | 2015-03-05 | |
| 2015-03-03 | TOWSE MATTHEW W Officer (SVP and Chief Financial Office) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,618 65,618 owned after | $16.66 exercise price | 2015-03-05 | |
| 2015-03-03 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +102,529 102,529 owned after | $16.66 exercise price | 2015-03-05 | |
| 2015-03-03 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −132 136 owned after | $4.54 exercise price | 2015-03-05 | |
| 2015-03-03 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +205,058 205,058 owned after | $16.66 exercise price | 2015-03-05 | |
| 2015-02-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −132 268 owned after | $4.54 exercise price | 2015-02-26 | |
| 2015-02-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 8,661 owned after | $2.11 exercise price | 2015-02-26 | |
| 2015-02-25 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 36,400 owned after | $9.96 exercise price | 2015-02-26 | |
| 2015-02-20 | LEWIS EARL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $13.88 exercise price | 2015-02-20 | |
| 2015-01-27 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −150 8,811 owned after | $2.11 exercise price | 2015-01-28 | |
| 2015-01-27 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 400 owned after | $4.54 exercise price | 2015-01-28 | |
| 2015-01-27 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 37,200 owned after | $9.96 exercise price | 2015-01-28 | |
| 2015-01-13 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −666 0 owned after | $6.84 exercise price | 2015-01-14 |